(Q43766971)

26 November 2017

title

Tetomilast suppressed production of proinflammatory cytokines from human monocytes and ameliorated chronic colitis in IL-10-deficient mice (English)

1 reference

26 November 2017

3

1 reference

26 November 2017

9

Toshifumi Hibi

1 reference

26 November 2017

Hitoshi Ichikawa

1

1 reference

26 November 2017

Susumu Okamoto

2

1 reference

26 November 2017

Hisashi Nagamoto

4

1 reference

26 November 2017

Mina T Kitazume

5

1 reference

26 November 2017

Taku Kobayashi

6

1 reference

26 November 2017

Hiroshi Chinen

7

1 reference

26 November 2017

Tadakazu Hisamatsu

8

1 reference

26 November 2017

publication date

1 November 2008

1 reference

Inflammatory Bowel Diseases

26 November 2017

published in

1 reference

26 November 2017

volume

14

1 reference

26 November 2017

issue

11

1 reference

26 November 2017

page(s)

1483-1490

1 reference

Inflammatory Bowel Disease

26 November 2017

cites work

1 reference

Novel pathophysiological concepts of inflammatory bowel disease

21 January 2018

1 reference

Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease

21 January 2018

1 reference

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury

21 January 2018

1 reference

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

Anti-interleukin-12 antibody for active Crohn's disease

21 January 2018

1 reference

New biological therapies in inflammatory bowel disease

21 January 2018

1 reference

Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis

21 January 2018

1 reference

Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

21 January 2018

1 reference

Cilomilast: orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

Effects of OPC-6535 on lipopolysaccharide-induced acute liver injury in the rat: involvement of superoxide and tumor necrosis factor-alpha from hepatic macrophages

21 January 2018

1 reference

Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli

21 January 2018

1 reference

Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10.

21 January 2018

1 reference

PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease

21 January 2018

1 reference

MAP kinases in the immune response

21 January 2018

1 reference

Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses

21 January 2018

1 reference

Animal models of inflammatory bowel disease

21 January 2018

1 reference

Inhibition of superoxide anion and elastase release in human neutrophils by 3'-isopropoxychalcone via a cAMP-dependent pathway

21 January 2018

1 reference

Potent inhibition of cytokine production from intestinal lamina propria T cells by phosphodiesterase-4 inhibitory thalidomide analogues

21 January 2018

1 reference

Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation

21 January 2018

1 reference

PGE/cAMP and GM-CSF synergise to induce a pro-tolerance cytokine profile in monocytic cell lines

21 January 2018

1 reference

Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.

21 January 2018

1 reference

Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanism.

21 January 2018

1 reference

Cyclic AMP-dependent protein kinase A and CREB are involved in neuregulin-induced synapse-specific expression of acetylcholine receptor gene

21 January 2018

1 reference

Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis

21 January 2018

1 reference

Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability.

21 January 2018

1 reference

Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20524

1 reference

26 November 2017

1 reference